Colo-60H Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The COLO-60H cell line was derived from a biopsy sample taken from an untreated adenocarcinoma in a male patient. Established in 1998, this cell line is of particular interest in cancer research due to its origin in colorectal cancer, a common and often lethal form of cancer that initiates in the lining of the colon or rectum. Adenocarcinomas themselves are characterized by the glandular origin of the tumor cells, which can provide insights into cellular processes such as secretion and absorption that are hijacked during cancer development. COLO-60H cells exhibit the HLA-A*0201 allele, making them a valuable model for immunological studies, particularly in the context of tumor immunology. The presence of this specific Human Leukocyte Antigen (HLA) type is crucial for the presentation of antigens to T cells, influencing the immune system's ability to recognize and destroy cancer cells. This characteristic supports the use of COLO-60H in assessing the efficacy of immunotherapeutic agents and in studying the interactions between tumor cells and the immune system in a histocompatible setting. The relevance of this cell line extends to pharmacological research, where it can be used to evaluate drug responses and explore mechanisms of resistance that are critical in the advancement of personalized medicine for colorectal cancer treatment. |
|---|---|
| Organism | Human |
| Tissue | Colon transversum |
| Disease | Adenocarcinoma |
| Synonyms | COLO-60H, COLO 60H, COLO60H |
Characteristics
| Age | 73 years |
|---|---|
| Gender | Male |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | COLO-60H (Cytion catalog number 300456) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_4572 |
Biomolecular Data
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 is recommended |
| Fluid renewal | Every 3 to 5 days |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300456-260825 | Certificate of Analysis | 22. Oct. 2025 | 300456 |
| 300456-416SF | Certificate of Analysis | 23. May. 2025 | 300456 |